A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2011
10/12/2011	CN102210662A Application of lutein in preparation of medicaments for preventing and treating cerebral vascular diseases
10/12/2011	CN102210658A Microcapsule soft capsule preparation with high alpha-linolenic acid content
10/12/2011	CN102210657A Prulifloxacin tablets and preparation process thereof
10/12/2011	CN102210656A Medicinal composition containing carbazochrome sodium sulfonate compound and preparation method thereof
10/12/2011	CN102210655A Cefpiramide sodium micro-spheres and preparing method thereof
10/12/2011	CN102210654A Dihydrotestosterone composition as spray
10/12/2011	CN102210653A Burdock aglycone microemulsion
10/12/2011	CN102210652A Lipid microsphere injection of larotaxel phospholipid compound, and preparation method thereof
10/12/2011	CN102210651A Nitrofurazone washing fluid, preparation method and application thereof
10/12/2011	CN102210650A Prednicarbate emulsifiable paste and preparation method thereof
10/12/2011	CN102210649A Amphotericin B cream and preparation method thereof
10/12/2011	CN102210648A High-concentration furacilin micro emulsion washing fluid and preparation method and use thereof
10/12/2011	CN102210647A Gel sustained-release preparation capable of improving ring-close rates of camptothecin and derivative lactone ring thereof
10/12/2011	CN102210645A Lutein ophthalmic nanocapsule in-situ gel preparation and preparation method thereof
10/12/2011	CN102210486A Atomized caffeine and atomizing method
10/12/2011	CN102210485A Method for aerosolizing caffeine or caffeine-containing substance
10/12/2011	CN101972446B Medicament for treating coronary disease and preparation method thereof
10/12/2011	CN101972399B Medicament for treating hypertension and preparation method thereof
10/12/2011	CN101972269B Medicament for treating dental ulcer and preparation method thereof
10/12/2011	CN101822741B Oral ulcer healing membrane with traditional Chinese medicine bioadhesive one-way medicine release
10/12/2011	CN101792477B Acetyl ursolic acid acylate triethanolamine monoester with anti-cancer activity and preparation method thereof
10/12/2011	CN101792444B Sodium levofolinate and preparation method and drug combination thereof
10/12/2011	CN101773512B 8-amino acid/11-vitamin containing micro granule capsule and preparation method thereof
10/12/2011	CN101766611B Medical composition of levamlodipine or pharmaceutically acceptable salt thereof and beta-blocker and application thereof
10/12/2011	CN101732332B Application of 20(S)-ginsenoside Rg3 in preparation of medicines for treating non-small cell lung cancer
10/12/2011	CN101732262B Method for preparing freeze-drying particle preparation for injection
10/12/2011	CN101717384B Compound in salvia miltiorrhiza bungered sage root injection and application thereof in curing treating cardiovascular disease
10/12/2011	CN101693011B Preparation method of magnetic medicine-carrying nano-particle
10/12/2011	CN101690727B Medicament for treating arthritis and preparation method thereof
10/12/2011	CN101669991B Gendarussa wine and manufacturing method and application thereof
10/12/2011	CN101616916B Crystalline forms of an 8-azabicyclo[3.2.1]octane compound
10/12/2011	CN101590031B preparation method of disodium sulfodehydroabietate (DSDA) and composition
10/12/2011	CN101507804B Medicine for injury pain and its preparation technique
10/12/2011	CN101496808B Compound xanthophyll microcapsule for sight protection and preparation method thereof
10/12/2011	CN101428112B Formulation for treating acne and preparation method thereof
10/12/2011	CN101428050B Active composition for treating thrombus, cardio-cerebrovascular system diseases
10/12/2011	CN101421252B 2,6-substituted-4-monosubstituted amino-pyrimidine as prostaglandin d2 receptor antagonists
10/12/2011	CN101415732B Aryl/alkyl vinyl sulfone hyaluronic acid derivatives
10/12/2011	CN101415680B Benzoisoindole derivatives for the treatment of pain
10/12/2011	CN101396358B Oxiracetam injection
10/12/2011	CN101390987B Cataplasma for treating anti-motility fatigue and preparation method thereof
10/12/2011	CN101389613B Macrocyclic factor viia inhibitors useful as anticoagulants
10/12/2011	CN101336929B Medicine for increasing intra-abdominal pressure
10/12/2011	CN101332261B External medicine for treating furunculosis
10/12/2011	CN101317921B Externally washing medicament for treating external hordeolum
10/12/2011	CN101306143B Ear drops for treating otitis media suppurativa acuta
10/12/2011	CN101296909B Pyrazine derivatives and use as pI3K inhibitors
10/12/2011	CN101287472B Antiviral 4'-substituted pre-nucleotide phosphoramidates
10/12/2011	CN101279993B 3-aryl-8-hydroxychromone-7-O-alpha-D-arabinofuranoside compound, synthetic method and use thereof
10/12/2011	CN101258134B 2-(4-oxo-4H-quinazolin-3-yl) acetamides and their use as vasopressin V3 antagonists
10/12/2011	CN101225383B RNA interference sequence and recombinant interference plasmid of fucosyl transferase I and IV for suppressing synthesis of LeY carbohydrate antigen
10/12/2011	CN101217870B Antimicrobial compositions containing synergistic combinations of quaternary ammonium compounds and essential oils and/or constituents thereof
10/12/2011	CN101204453B Tincture medicine for perennial allergic rhinitis
10/12/2011	CN101199847B Drug compound for AT1 receptor antagonist/diuretic/folate coupling and uses thereof
10/12/2011	CN101199610B Paste medicament for treating acute appendicitis
10/12/2011	CN101198326B Combined pharmaceutical preparation for treatment of type 2 diabetes
10/12/2011	CN101195013B Snuffing medicament for treating cold toothache
10/12/2011	CN101195006B Exterior applying medicament for treating toothache due to pathogenic wind-fire
10/12/2011	CN101194943B Fumigation medicament for treating anoschisis
10/12/2011	CN101185704B Powder agent medicine for treating aphtha
10/12/2011	CN101185683B Cream shape medicine for treating infantile sweatful symptoms
10/12/2011	CN101181370B Medicine for treating colitis
10/12/2011	CN101175734B Quinazoline derivatives as antineoplastic medicine and its production method
10/12/2011	CN101146808B Phenyl methanone derivatives and their use as glycine transporter 1 inhibitors
10/12/2011	CN101139358B Ethoxy combretastatin and preparation and use of its prodrug
10/12/2011	CN101002765B Compressed formed preparation
10/11/2011	US8034977 Lipids for transfection of nucleic acids
10/11/2011	US8034964 Phosphaplatins and their use in the treatment of cancers resistant to cisplatin and carboplatin
10/11/2011	US8034959 Methods of treating cancer with an antibody-drug conjugate
10/11/2011	US8034958 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
10/11/2011	US8034955 triterpenoids such as 2-cyano-3,12-dioxoolean-1,9-dien-28oic acid, used for inhibiting gamma -inteferon-induced nitric oxide production in macrophages; preventing cancer, Alzheimer's disease, Parkinson's disease, inflammatory bowel diseases, and multiple sclerosis
10/11/2011	US8034954 Calcium channel antagonists
10/11/2011	US8034953 Modulators of indoleamine 2,3-dioxygenase and methods of using the same
10/11/2011	US8034949 Pyrrolidine compound and a process for preparing the same
10/11/2011	US8034946 Biphenyl compounds useful as muscarinic receptor antagonists
10/11/2011	US8034940 Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
10/11/2011	US8034939 Isoindole derivatives, compositions containing same, preparation thereof and pharmaceutical uses thereof in particular as inhibitors of chaperone protein Hsp90 activities
10/11/2011	US8034938 Imidazo[4,5-c]quinolines, 6,7,8,9-tetrahydroimidazo[4,5-c]quinolines, imidazo[4,5-c]naphthyridines, and 6,7,8,9-tetrahydroimidazo[4,5-c]naphthyridines) with a CH( R1) group in the fused ring at 1-position of imidazo ring; modulate immune response, by induction of cytokine biosynthesis or other mechanism
10/11/2011	US8034937 e.g.1'-[(6-chloro-1H-indol-3-yl)carbonyl]-7H-spiro[furo[3,4-b]pyridine-5,4'-piperidine]; vasopressin V1a receptor antagonist; antidepressant and anxiolytic agent; dysmenorrhea, hypertension, chronic heart failure, inappropriate secretion of vasopressin, liver cirrhosis, nephrotic syndrome
10/11/2011	US8034936 Spirocyclic cyclohexane compounds useful to treat substance dependency
10/11/2011	US8034933 graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis; human immunodeficiency viricides
10/11/2011	US8034922 Compositions and methods for modulating activity of capped small RNAs
10/11/2011	US8034921 IRNA agents targeting CCR5 expressing cells and uses thereof
10/11/2011	US8034913 Recombinantly modified plasmin
10/11/2011	US8034908 Glycolipids and synthetic method thereof as well as their synthetic intermediates, and synthetic method thereof
10/11/2011	US8034845 administering to animals antibiotic deriavtives such as florfenicol or flunixin, for prevention of urogenital, respiratory system and gastrointestinal disorders, vision defects and mastitis; veterinary medicine
10/11/2011	US8034844 Compositions having a high antiviral efficacy
10/11/2011	US8034843 cannabis extract; containing a pharmaceutically acceptable amount of CBD and/or CBDA and/or the propyl variants CBDV and/or CBDVA
10/11/2011	US8034842 Compounds
10/11/2011	US8034841 Method for placental exfoliation using oxo-arachidonic acid or the like
10/11/2011	US8034839 Method of treating ocular allergy
10/11/2011	US8034838 Composition and method for the treatment of neurological disorders
10/11/2011	US8034837 Polymorphic form of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid
10/11/2011	US8034836 Amino acid compounds
10/11/2011	US8034835 1-[[2-amino-3-(substituted alkyl)-3H-benzimidazolyl[methyl]-3-substituted-1,3-dihydro-benzoimidazol-2-ones and structural analogs
10/11/2011	US8034834 Method for treating proliferative disorders with HSP90 inhibitors
10/11/2011	US8034833 Phosphorus binder for treatment of renal disease
10/11/2011	US8034832 Gyrase inhibitors and uses thereof
10/11/2011	US8034831 Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies
10/11/2011	US8034830 Argatroban formulation

1 ... 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 ... 7860